Baicalein and Gestational Diabetes
Author Information
Author(s): Yao Jun, Pan Jiaying, Jiang Qiaoying, Wang Hui, Zhao Yiqi
Primary Institution: Center for Reproductive Medicine, Department of Obstetrics, Zhejiang Provincial People’s Hospital, Hangzhou Medical College
Hypothesis
Baicalein can mitigate the effects of gestational diabetes mellitus (GDM) by inhibiting NLRP3 inflammasome activation and reducing inflammation and oxidative stress.
Conclusion
Baicalein effectively inhibits the NLRP3 inflammasome and alleviates placental inflammation and oxidative stress associated with GDM in mice.
Supporting Evidence
- Baicalein improved glucose tolerance and insulin sensitivity in GDM mice.
- Fasting blood glucose and plasma insulin levels were normalized with Baicalein treatment.
- Baicalein positively influenced litter size and birth weight in GDM mice.
- Inflammation markers IL-1β, IL-18, and NLRP3 were reduced after Baicalein administration.
Takeaway
Baicalein is a natural compound that helps pregnant mice with diabetes by reducing inflammation and improving their health.
Methodology
The study used a GDM mouse model to assess the effects of Baicalein on glucose tolerance, insulin sensitivity, and inflammation markers.
Limitations
Further investigation using human samples and additional cell models is needed.
Participant Demographics
C57BL/KsJ+/+ and C57BL/KsJdb/+ mice, 10 weeks old, with equal representation of both sexes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website